Taiwan Bio Therapeutics Co., Ltd (TPEX:6892)
Taiwan
· Delayed Price · Currency is TWD 34.65
+1.15 (3.43%)
Jun 13, 2025, 1:54 PM CST
Taiwan Bio Therapeutics Market Cap
Taiwan Bio Therapeutics has a market cap or net worth of 2.93 billion as of June 13, 2025. Its market cap has increased by 55.27% in one year.
Market Cap
2.93B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
34.65
Market Cap Chart
Since May 13, 2022, Taiwan Bio Therapeutics's market cap has increased from 1.93B to 2.93B, an increase of 51.80%. That is a compound annual growth rate of 14.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2025 | 2.83B | -19.93% |
| Dec 31, 2024 | 3.54B | 103.07% |
| Dec 29, 2023 | 1.74B | 7.86% |
| Dec 30, 2022 | 1.62B | -16.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 183.96B |
| Caliway Biopharmaceuticals | 149.82B |
| Bora Pharmaceuticals Co., LTD. | 85.03B |
| Lotus Pharmaceutical | 58.11B |
| Polaris Group | 33.59B |
| Lumosa Therapeutics | 28.19B |
| Center Laboratories | 27.60B |
| Oneness Biotech | 27.55B |